MedCity News November 20, 2024
Steve Goldberg

We cannot change the fact that some patients must take multiple drugs, but we can certainly change how we manage it with careful coordination and communication among healthcare providers, and personalized medicine practices such as pharmacogenomics.

In today’s healthcare system, we stand at a critical crossroads when it comes to medication management. For decades, the practice of polypharmacy — prescribing multiple drugs to treat various symptoms and conditions — has been the default approach, particularly for older adults and patients with chronic illnesses. However, this one-size-fits-all method is failing too many. The consequences of this scattershot approach are clear: a rising tide of adverse drug reactions, ineffective treatments, and overwhelming costs that burden both patients and the system.

To improve...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma, Pharma / Biotech, Provider
What might a Trump administration mean for the Biosecure Act?
Q&A: Reducing Mental Health Stigma Starts in Pharmacies
Flagship, Pfizer alliance yields two more startup deals
Payment Disrupters and Opportunities: Key Trends That Impacted Pharmacy in 2024
GeneDx Launches Tool to Fuel Rare Disease Drug Discovery

Share This Article